NASDAQ:AZRX - AzurRx BioPharma SEC Filings & 10K Form

$0.95
-0.10 (-9.56 %)
(As of 07/18/2019 04:00 PM ET)
Today's Range
$0.9052
Now: $0.9465
$1.05
50-Day Range
$1.05
MA: $1.69
$2.2107
52-Week Range
$0.91
Now: $0.9465
$3.75
Volume1.65 million shs
Average Volume121,812 shs
Market Capitalization$19.93 million
P/E RatioN/A
Dividend YieldN/A
Beta2.23

SEC Filings

AzurRx BioPharma (NASDAQ:AZRX) SEC Filings

DateFilerForm TypeView
07/17/2019
3:57 PM
AzurRx BioPharma (Filer)
Form 424B5
View Filing
07/10/2019
1:36 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/02/2019
5:46 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
5:42 PM
AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
5:41 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
5:37 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2019
11:15 PM
AzurRx BioPharma (Filer)
Form EFFECT
View Filing
06/21/2019
7:10 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4/A
View Filing
06/21/2019
7:08 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4/A
View Filing
06/21/2019
7:04 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4/A
View Filing
06/21/2019
7:01 PM
AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4/A
View Filing
06/21/2019
4:25 PM
AzurRx BioPharma (Filer)
Form S-3/A
View Filing
06/21/2019
4:23 PM
AzurRx BioPharma (Filer)
Form 424B3
View Filing
06/17/2019
8:51 PM
AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
8:50 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
8:49 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/17/2019
8:48 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/09/2019
11:19 PM
AzurRx BioPharma (Filer)
Form EFFECT
View Filing
06/07/2019
4:00 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/05/2019
8:36 AM
AzurRx BioPharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
06/04/2019
8:45 PM
AzurRx BioPharma (Filer)
Form S-3/A
View Filing
05/23/2019
4:01 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/20/2019
4:00 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/15/2019
4:17 PM
AzurRx BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/14/2019
3:05 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2019
8:28 AM
AzurRx BioPharma (Filer)
Form 424B5
View Filing
05/07/2019
12:03 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/30/2019
4:24 PM
AzurRx BioPharma (Filer)
Form 10-K/A
View Filing
04/29/2019
7:27 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/29/2019
7:24 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/29/2019
7:22 PM
AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/29/2019
7:20 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/24/2019
2:15 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/11/2019
8:50 AM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/02/2019
7:56 AM
AzurRx BioPharma (Filer)
Form 424B5
View Filing
04/01/2019
3:41 PM
AzurRx BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/26/2019
4:00 PM
AzurRx BioPharma (Subject)
Ross Edmund Burke Jr. (Filed by)
Form SC 13D/A
View Filing
02/20/2019
7:29 AM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/19/2019
8:45 PM
AzurRx BioPharma (Issuer)
Ross Edmund Burke Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
10:23 AM
AzurRx BioPharma (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2019
3:42 PM
AzurRx BioPharma (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G/A
View Filing
01/29/2019
2:44 PM
AzurRx BioPharma (Subject)
BALK MATTHEW (Filed by)
Form SC 13G/A
View Filing
01/07/2019
5:49 PM
AzurRx BioPharma (Issuer)
Ross Edmund Burke Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/02/2019
5:47 PM
AzurRx BioPharma (Issuer)
Spoor Johan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/02/2019
5:44 PM
AzurRx BioPharma (Issuer)
Shenouda Maged (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/02/2019
5:03 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/02/2019
5:01 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/02/2019
4:58 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/02/2019
4:55 PM
AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2018
4:07 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/13/2018
3:39 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/04/2018
8:37 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/09/2018
3:41 PM
AzurRx BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/08/2018
12:46 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/01/2018
2:27 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/22/2018
3:07 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/01/2018
7:05 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/01/2018
7:03 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/01/2018
6:59 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/01/2018
6:56 PM
AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/24/2018
3:36 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/29/2018
3:05 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/13/2018
4:22 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/26/2018
5:24 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/26/2018
5:22 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4/A
View Filing
07/23/2018
4:05 PM
AzurRx BioPharma (Filer)
Form DEF 14A
View Filing
07/19/2018
12:20 PM
AzurRx BioPharma (Issuer)
Pennington James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/18/2018
10:57 AM
AzurRx BioPharma (Issuer)
Dupret Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/17/2018
7:57 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/16/2018
8:08 PM
AzurRx BioPharma (Issuer)
Spoor Johan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/16/2018
6:23 PM
AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/16/2018
6:22 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/16/2018
6:20 PM
AzurRx BioPharma (Issuer)
Shenouda Maged (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/16/2018
6:18 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/16/2018
3:47 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/12/2018
11:15 PM
AzurRx BioPharma (Filer)
Form EFFECT
View Filing
07/11/2018
12:27 PM
AzurRx BioPharma (Filer)
Form S-3/A
View Filing
07/03/2018
4:16 PM
AzurRx BioPharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
06/04/2018
5:00 PM
AzurRx BioPharma (Issuer)
Pennington James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/01/2018
4:28 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/14/2018
4:14 PM
AzurRx BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/11/2018
2:32 PM
AzurRx BioPharma (Subject)
LYTTON LAURENCE W (Filed by)
Form SC 13G
View Filing
05/11/2018
12:35 PM
AzurRx BioPharma (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
View Filing
05/01/2018
8:12 AM
AzurRx BioPharma (Filer)
Form S-3MEF
View Filing
04/23/2018
3:15 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/20/2018
5:55 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/02/2018
3:17 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/02/2018
3:16 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/02/2018
3:14 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
4:07 PM
AzurRx BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/13/2018
4:31 PM
AzurRx BioPharma (Issuer)
CASAMENTO CHARLES J (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/13/2018
4:29 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/13/2018
4:20 PM
AzurRx BioPharma (Issuer)
Riddell Alastair (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/13/2018
4:18 PM
AzurRx BioPharma (Issuer)
Schramm Vern Lee (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
01/19/2018
4:25 PM
AzurRx BioPharma (Filer)
Form 424B3
View Filing
01/17/2018
5:23 AM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/16/2018
5:13 PM
AzurRx BioPharma (Issuer)
BORKOWSKI EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/08/2018
6:30 AM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/05/2018
4:05 PM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/04/2017
8:44 AM
AzurRx BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 7/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel